v3.25.2
CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY (UNAUDITED) - USD ($)
$ in Thousands
Total
Preferred Stock [Member]
Series A convertible preferred stock [Member]
Preferred Stock [Member]
Series A-1 convertible preferred stock [Member]
Preferred Stock [Member]
Series B convertible preferred stock [Member]
Common Stock [Member]
Additional Paid-in Capital [Member]
AOCI Attributable to Parent [Member]
Accumulated Deficit [Member]
Beginning balance at Dec. 31, 2023   $ 47,458 $ 4,132 $ 59,855        
Beginning balance, Shares at Dec. 31, 2023   2,286,873 312,094 2,625,896        
Beginning balance, Shares at Dec. 31, 2023         359,569      
Beginning balance at Dec. 31, 2023 $ (182,921)       $ 1 $ 4,159   $ (187,081)
Conversion of convertible preferred stock to common stock in connection with the Merger, Share   (2,286,873) (312,094) (2,625,896) 5,224,863      
Conversion of convertible preferred stock to common stock in connection with the Merger, Value 111,445 $ (47,458) $ (4,132) $ (59,855) $ 1 111,444    
Issuance of common stock in the pre-closing financing, Shares         1,682,045      
Issuance of common stock in the pre-closing financing, Value 42,000         42,000    
Issuance of common stock for conversion of convertible notes, Shares         1,433,410      
Issuance of common stock for conversion of Convertible Notes, Value 22,705         22,705    
Issuance of common stock to Homology shareholders in reverse recapitalization, Shares         3,229,633      
Issuance of common stock to Homology shareholders in reverse recapitalization, Value 64,292         64,292    
Reverse recapitalization transaction costs (10,013)         (10,013)    
Issuance of CVR at fair value (180)         (180)    
Stock-based compensation expense 417         417    
Other comprehensive loss (5)           $ (5)  
Net loss 1,029             1,029
Ending balance, Shares at Mar. 31, 2024   0 0 0        
Ending balance at Mar. 31, 2024   $ 0 $ 0 $ 0        
Ending balance, Shares at Mar. 31, 2024         11,929,520      
Ending balance at Mar. 31, 2024 48,769       $ 2 234,824 (5) (186,052)
Beginning balance at Dec. 31, 2023   $ 47,458 $ 4,132 $ 59,855        
Beginning balance, Shares at Dec. 31, 2023   2,286,873 312,094 2,625,896        
Beginning balance, Shares at Dec. 31, 2023         359,569      
Beginning balance at Dec. 31, 2023 (182,921)       $ 1 4,159   (187,081)
Other comprehensive loss (1)              
Net loss (15,949)              
Ending balance, Shares at Jun. 30, 2024   0 0 0        
Ending balance at Jun. 30, 2024   $ 0 $ 0 $ 0        
Ending balance, Shares at Jun. 30, 2024         11,995,206      
Ending balance at Jun. 30, 2024 33,511       $ 2 236,540 (1) (203,030)
Beginning balance at Mar. 31, 2024   $ 0 $ 0 $ 0        
Beginning balance, Shares at Mar. 31, 2024   0 0 0        
Beginning balance, Shares at Mar. 31, 2024         11,929,520      
Beginning balance at Mar. 31, 2024 48,769       $ 2 234,824 (5) (186,052)
Issuance of common stock from option exercises, Shares         53,077      
Issuance of common stock from option exercises           380    
Issuance Of Common Stocks From Rsu Vesting, Shares         12,609      
Stock-based compensation expense 1,336         1,336    
Other comprehensive loss 4           4  
Net loss (16,978)             (16,978)
Ending balance, Shares at Jun. 30, 2024   0 0 0        
Ending balance at Jun. 30, 2024   $ 0 $ 0 $ 0        
Ending balance, Shares at Jun. 30, 2024         11,995,206      
Ending balance at Jun. 30, 2024 33,511       $ 2 236,540 $ (1) (203,030)
Beginning balance, Shares at Dec. 31, 2024         12,197,615      
Beginning balance at Dec. 31, 2024 5,675       $ 2 240,487   (234,814)
Stock-based compensation expense 1,342         1,342    
Net loss (11,031)             (11,031)
Ending balance, Shares at Mar. 31, 2025         12,197,615      
Ending balance at Mar. 31, 2025 (4,014)       $ 2 241,829   (245,845)
Beginning balance, Shares at Dec. 31, 2024         12,197,615      
Beginning balance at Dec. 31, 2024 $ 5,675       $ 2 240,487   (234,814)
Issuance of common stock from option exercises, Shares 0              
Other comprehensive loss $ 0              
Net loss (20,520)              
Ending balance, Shares at Jun. 30, 2025         12,197,615      
Ending balance at Jun. 30, 2025 (12,235)       $ 2 243,097   (255,334)
Beginning balance, Shares at Mar. 31, 2025         12,197,615      
Beginning balance at Mar. 31, 2025 (4,014)       $ 2 241,829   (245,845)
Stock-based compensation expense 1,268         1,268    
Other comprehensive loss 0              
Net loss (9,489)             (9,489)
Ending balance, Shares at Jun. 30, 2025         12,197,615      
Ending balance at Jun. 30, 2025 $ (12,235)       $ 2 $ 243,097   $ (255,334)